QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea
NCT01071694 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2012-04-16
Summary
This study is to describe the quality of life of Korean patients with early relapsing-remitting multiple sclerosis during the initial 1 year of treatment with Betaferon with several validated questionnaires.
Conditions
- Multiple Sclerosis, Relapsing-Remitting
Interventions
- DRUG
-
Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)
Patients receiving Betaferon according to routine clinical practice
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- South Korea
More Related Trials
-
Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis
NCT00370071 ·Status: COMPLETED ·Phase: PHASE3
-
Betaferon® Regulatory Post-Marketing Surveillance
NCT01414816 ·Status: COMPLETED
-
A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability
NCT01404117 ·Status: WITHDRAWN ·Phase: PHASE2
-
Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon
NCT01766063 ·Status: COMPLETED
-
Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)
NCT00313976 ·Status: WITHDRAWN ·Phase: PHASE3
-
Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis
NCT01491100 ·Status: COMPLETED
-
Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis
NCT00906399 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Safety and Efficacy Study of Peginterferon Beta-1a
NCT01332019 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis
NCT01184833 ·Status: COMPLETED
-
An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis
NCT01142557 ·Status: COMPLETED
-
Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)
NCT00439257 ·Status: COMPLETED
-
Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors
NCT01235455 ·Status: COMPLETED
-
An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy
NCT01141751 ·Status: COMPLETED
-
Rehabilitation Study in MS Patients
NCT00780455 ·Status: TERMINATED ·Phase: PHASE4
-
BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program
NCT01233245 ·Status: COMPLETED
-
The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
NCT00917839 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b
NCT03408093 ·Status: COMPLETED
-
An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone
NCT01142518 ·Status: COMPLETED
-
Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?
NCT00534261 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment
NCT00787657 ·Status: COMPLETED
-
Physical Disability in Patients Treated With Betaferon
NCT00873340 ·Status: COMPLETED
-
Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study
NCT03134573 ·Status: COMPLETED
-
National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis
NCT02937285 ·Status: COMPLETED ·Phase: PHASE3
-
Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
NCT00461396 ·Status: COMPLETED
-
Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis
NCT00235989 ·Status: COMPLETED ·Phase: PHASE2